This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sookoian, S. Articles by Pirola, C. J. Search for Related Content PubMed PubMed Citation Articles by Sookoian, S. Articles by Pirola, C. J. Pubmed/NCBI databases Medline Plus Health Information Metabolic Syndrome Social Bookmarking                         What's this?

Review: Genetics of the cardiometabolic syndrome: new insights and therapeutic implications

Departamento de Sustancias Vasoactivas y Cardiología Molecular, Instituto de Investigaciones A Lanari, Universidad de Buenos Aires-CONICET, Ciudad Autónoma de Buenos Aires, Argentina

Carlos J. Pirola

Departamento de Sustancias Vasoactivas y Cardiología Molecular, Instituto de Investigaciones A Lanari, Universidad de Buenos Aires-CONICET, Ciudad Autónoma de Buenos Aires, Argentina, carlospirola{at}ciudad.com.ar, pirola.carlos@lanari. fmed.uba.ar

Although the definition of the phenotype is imprecise, cardiometabolic syndrome (CMS) includes a constellation of complex diseases such as type 2 diabetes, dislipidemias, central obesity and hypertension, proinflammatory and prothrombotic states, ovarian polycystosis and fatty liver. The genetics of each disease is complex in itself and varies in spectrum from monogenic and syndromic models of inheritance, usually rare, to the most common polygenic and multifactorial forms. In addition, human studies using the candidate-gene approach indicate that common genetic variants of several genes are associated with the development of CMS. Genome-wide scans have also provided several chromosomal regions associated with some of the components of CMS. In addition, through comparative genomics animal models can generate a map for candidate loci in humans and a promising approach is offered by bioinformatic tools for gene prioritization. Lastly, the involvement of genes whose products are already the targets for approved drugs, such as SLC6A4, PPAR and PPAR , in the development of CMS suggests new avenues for CMS pharmacological treatment.

Key Words: cardiometabolic syndrome • metabolic syndrome • insulin resistance • obesity • hypertension • diabetes • genetics • gene • variants.

References

• Adie, E.A. et al. (2006) SUSPECTS: enabling fast and effective prioritization of positional candidates, Bioinformatics 22: 773—774.[Abstract/Free Full Text]
• Aerts, S. et al. (2006) Gene prioritization through genomic data fusion, Nat Biotechnol 24: 537—544.[CrossRef][Medline] [Order article via Infotrieve]
• Alberti, K.G. et al. (2005) The metabolic syndrome — a new worldwide definition, Lancet 366: 1059—1062.[CrossRef][Medline] [Order article via Infotrieve]
• Alberti, K.G., Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med 15: 539—553.[CrossRef][Medline] [Order article via Infotrieve]
• Altshuler, D. et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes, Nat Genet 26: 76—80.[CrossRef][Medline] [Order article via Infotrieve]
• Andersen, G. et al. (2006) Studies of the association of the GNB3 825C> T polymorphism with components of the metabolic syndrome in white Danes, Diabetologia 49: 75—82.[CrossRef][Medline] [Order article via Infotrieve]
• Arya, R. et al. (2002) Factors of insulin resistance syndrome — related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic mexican—americans, Diabetes 51: 841—847.[Abstract/Free Full Text]
• Barker, D.J. et al. (1990) Fetal and placental size and risk of hypertension in adult life, Br Med J 301: 259—262.[Abstract/Free Full Text]
• Binder, A. (2007) A review of the genetics of essential hypertension, Curr Opin Cardiol 22: 176—184.[Medline] [Order article via Infotrieve]
• Chanock, S.J. et al. (2007) Replicating genotype— phenotype associations, Nature 447: 655—660.[CrossRef][Medline] [Order article via Infotrieve]
• Chinetti-Gbaguidi, G. et al. (2005) Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy, Curr Opin Pharmacol 5: 177—183.[CrossRef][Medline] [Order article via Infotrieve]
• Connolly, H.M. et al. (1997) Valvular heart disease associated with fenfluramine—phentermine, N Engl J Med 337: 581—588.[Abstract/Free Full Text]
• Costa, L.A. et al. (2002) The ACE insertion/deletion polymorphism is not associated with the metabolic syndrome (WHO Definition) in Brazilian type 2 diabetic patients, Diabetes Care 25: 2365—2366.[Free Full Text]
• Cowley, A.W. (2006) The genetic dissection of essential hypertension, Nat Rev Genet 7: 829—840.[Medline] [Order article via Infotrieve]
• Despres, J.P. and Lemieux, I. (2006) Abdominal obesity and metabolic syndrome, Nature 444: 881—887.[CrossRef][Medline] [Order article via Infotrieve]
• Desvergne, B. and Wahli, W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocr Rev 20: 649—688.[Abstract/Free Full Text]
• Di, M. et al. (2004) The endocannabinoid system and its therapeutic exploitation, Nat Rev Drug Discov 3: 771—784.[CrossRef][Medline] [Order article via Infotrieve]
• Dina, C. et al. (2007) Comment on "A common genetic variant is associated with adult and childhood obesity", Science 315: 187.
• Dubern, B. et al. (2001) Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha—melanocyte—stimulating hormone genes in severely obese children, J Pediatr 139: 204—209.[CrossRef][Medline] [Order article via Infotrieve]
• Erkkila, A.T. et al. (2002) Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease, Nutr Metab Cardiovasc Dis 12: 53—59.[Medline] [Order article via Infotrieve]
• Farooqi, I.S. (2006) Monogenic human obesity syndromes, Prog Brain Res 153: 119—125.[Medline] [Order article via Infotrieve]
• Farooqi, I.S. et al. (2003) Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene, N Engl J Med 348: 1085.[Abstract/Free Full Text]
• Ford, E.S. et al. (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, J Am Med Assoc 287: 356—359.[Abstract/Free Full Text]
• Francis, G.A. et al. (2006) Peroxisomal proliferator activated receptor—gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3), BMC Med Genet 7: 3.
• Gemma, C. et al. (2006) Mitochondrial DNA Depletion in Small— and Large—for—Gestational— Age Newborns, Obesity (Silver Spring) 14: 2193—2199.[Medline] [Order article via Infotrieve]
• Guettier, J.M. et al. (2005) Polymorphisms in the fatty acid—binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population, J Clin Endocrinol Metab 90: 1705—1711.[Abstract/Free Full Text]
• Hainer, V. et al. (2006) Serotonin and norepinephrine reuptake inhibition and eating behavior, Ann NY Acad Sci 1083: 252—269.[CrossRef][Medline] [Order article via Infotrieve]
• Hegele, R.A. (2001) Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism, Am J Hum Genet 69: 1161—1177.[CrossRef][Medline] [Order article via Infotrieve]
• Hegele, R.A. (2005) Genetic and physiological insights into the metabolic syndrome, Am J Physiol Regul Integr Comp Physiol 289: R663—R669.[CrossRef]
• Hegele, R.A. et al. (2001) Common genomic variation in LMNA modulates indexes of obesity in Inuit, J Clin Endocrinol Metab 86: 2747—2751.[Abstract/Free Full Text]
• Heils, A. et al. (1996) Allelic variation of human serotonin transporter gene expression, J Neurochem 66: 2621—2624.[Medline] [Order article via Infotrieve]
• Herbert, A. et al. (2006) A common genetic variant is associated with adult and childhood obesity, Science 312: 279—283.[Abstract/Free Full Text]
• Hotamisligil, G.S. (2003) Inflammatory pathways and insulin action, Int J Obes Relat Metab Disord 27(Suppl 3): S53—S55.[CrossRef]
• Hotamisligil, G.S. (2006) Inflammation and metabolic disorders, Nature 444: 860—867.[CrossRef][Medline] [Order article via Infotrieve]
• Kahn, R. (2007) Metabolic syndrome: is it a syndrome? Does it matter? Circulation 115: 1806—1810.[Free Full Text]
• Kajantie, E. (2006) Fetal origins of stress-related adult disease, Ann NY Acad Sci 1083: 11—27.[CrossRef][Medline] [Order article via Infotrieve]
• Kelley, D.E. et al. (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes, Diabetes 51: 2944—2950.[Abstract/Free Full Text]
• Kissebah, A.H. et al. (2000) Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome, Proc Natl Acad Sci USA 97: 14478—14483.[Abstract/Free Full Text]
• Kyrou, I. et al. (2006) The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome, Ann NY Acad Sci 1083: 270—305.[CrossRef][Medline] [Order article via Infotrieve]
• Langefeld, C.D. et al. (2004) Linkage of the metabolic syndrome to 1q23—q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study, Diabetes 53: 1170—1174.[Abstract/Free Full Text]
• Lee, H.K. et al. (2005) Mitochondria-based model for fetal origin of adult disease and insulin resistance, Ann NY Acad Sci 1042: 1—18.[CrossRef][Medline] [Order article via Infotrieve]
• Lee, Y.J. and Tsai, J.C. (2002) ACE gene insertion/ deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients, Diabetes Care 25: 1002—1008.[Abstract/Free Full Text]
• Loos, R.J. et al. (2003) Genome-wide linkage scan for the metabolic syndrome in the HERITAGE Family Study, J Clin Endocrinol Metab 88: 5935—5943.[Abstract/Free Full Text]
• Loos, R.J. et al. (2007) Comment on "A common genetic variant is associated with adult and childhood obesity", Science 315: 187.
• Lopez-Bigas, N. and Ouzounis, C.A. (2004) Genome-wide identification of genes likely to be involved in human genetic disease, Nucleic Acids Res 32: 3108—3114.[Abstract/Free Full Text]
• Mani, A. et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 126—128.
• Martin, S., Nicaud, V. et al. (2003) Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges, Biochim Biophys Acta 1637: 217—225.[Medline] [Order article via Infotrieve]
• Mein, C.A. et al. (2005) Selection of candidate genes in hypertension, Methods Mol Med 108: 107—129.
• Meirhaeghe, A. et al. (2005) Lack of association between certain candidate gene polymorphisms and the metabolic syndrome, Mol Genet Metab 86: 293—299.[CrossRef][Medline] [Order article via Infotrieve]
• Miller, M. et al. (2007) APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome, Arch Med Res 38: 444—451.[CrossRef][Medline] [Order article via Infotrieve]
• Mootha, V.K. et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet 34: 267—273.[CrossRef][Medline] [Order article via Infotrieve]
• Muller, T.D. et al. (2007) No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents, Mol Genet Metab 90: 429—434.[CrossRef][Medline] [Order article via Infotrieve]
• Multiple authors (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature 447: 661—678.[CrossRef][Medline] [Order article via Infotrieve]
• Mutch, D.M. and Clement, K. (2006) Unraveling the genetics of human obesity, PLoS Genet 2: e188.[CrossRef][Medline] [Order article via Infotrieve]
• Nathan, D.M. (2007) Rosiglitazone and Cardiotoxicity — Weighing the Evidence, N Engl J Med.
• Ncep. (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), J Am Med Assoc 285: 2486—2497.[Free Full Text]
• Neve, B.P. et al. (2000) Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis, Biochem Pharmacol 60: 1245—1250.[CrossRef][Medline] [Order article via Infotrieve]
• Nisoli, E. et al. (2007) Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 100: 795—806.[Abstract/Free Full Text]
• Olivieri, O. et al. (2003) Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease, J Lipid Res 44: 2374—2381.[Abstract/Free Full Text]
• Pausova, Z. et al. (2000) Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians, Hypertension 36: 14—19.[Abstract/Free Full Text]
• Perez-Iratxeta, C. et al. (2002) Association of genes to genetically inherited diseases using data mining, Nat Genet 31: 316—319.[Medline] [Order article via Infotrieve]
• Pollex, R.L. et al. (2006) Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations, Atherosclerosis 184: 121—129.[CrossRef][Medline] [Order article via Infotrieve]
• Porter, J.R. and Barrett, T.G. (2005) Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure, J Med Genet 42: 893—902.[Abstract/Free Full Text]
• Pravenec, M. and Kurtz, T.W. (2007) Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies, Hypertension 49: 941—952.[Abstract/Free Full Text]
• Redon, R. et al. (2006) Global variation in copy number in the human genome, Nature 444: 444—454.[CrossRef][Medline] [Order article via Infotrieve]
• Russo, P. et al. (2007) Genetic Variations at the Endocannabinoid Type 1 Receptor Gene (CNR1) Are Associated with Obesity Phenotypes in Men, J Clin Endocrinol Metab 92: 2382—2386.[Abstract/Free Full Text]
• Saxena, R. et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, Science 316: 1331—1336.[Abstract/Free Full Text]
• Schoonjans, K. et al. (1996) PPARalpha and PPARgamma activators direct a distinct tissuespecific transcriptional response via a PPRE in the lipoprotein lipase gene, EMBO J 15: 5336—5348.[Medline] [Order article via Infotrieve]
• Schupp, M. et al. (2005) Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity, Diabetes 54: 3442—3452.[Abstract/Free Full Text]
• Scott, L.J. et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, Science 316: 1341—1345.[Abstract/Free Full Text]
• Shih, D.Q. and Stoffel, M. (2002) Molecular etiologies of MODY and other early-onset forms of diabetes, Curr Diab Rep 2: 125—134.[Medline] [Order article via Infotrieve]
• Siffert, W. (2005) G protein polymorphisms in hypertension, atherosclerosis, and diabetes, Annu Rev Med 56: 17—28.[CrossRef][Medline] [Order article via Infotrieve]
• Smith, A.J. et al. (2007) INSIG2 gene polymorphism is not associated with obesity in Caucasian, Afro-Caribbean and Indian subjects, Int J Obes (Lond).
• Sonnenberg, G.E. et al. (2004) A novel pathway to the manifestations of metabolic syndrome, Obes Res 12: 180—186.[Medline] [Order article via Infotrieve]
• Sookoian, S. et al. (2005a) Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents, J Mol Endocrinol 35: 373—380.[Abstract/Free Full Text]
• Sookoian, S. et al. (2005b) The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome, Am J Hypertens 18: 1271—1275.[CrossRef][Medline] [Order article via Infotrieve]
• Sookoian, S. et al. (2005c) Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome, Obes Res 13: 2122—2131.[Medline] [Order article via Infotrieve]
• Sookoian, S. et al. (2007) Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents, Obesity (Silver Spring) 15: 271—276.
• Stancakova, A. et al. (2006) Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome, Physiol Res 55: 483—490.[Medline] [Order article via Infotrieve]
• Stoll, M. et al. (2000) New target regions for human hypertension via comparative genomics, Genome Res 10: 473—482.[Abstract/Free Full Text]
• Tenenbaum, A. et al. (2005) Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons, Cardiovasc Diabetol 4: 14.[CrossRef][Medline] [Order article via Infotrieve]
• Turek, F.W. et al. (2005) Obesity and metabolic syndrome in circadian Clock mutant mice, Science 308: 1043—1045.[Abstract/Free Full Text]
• van Driel, M.A. et al. (2005) GeneSeeker: extraction and integration of human disease-related information from web-based genetic databases, Nucleic Acids Res 33: W758—W761.[Abstract/Free Full Text]
• Vimaleswaran, K.S. et al. (2006) Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians, Metabolism 55: 1222—1226.[CrossRef][Medline] [Order article via Infotrieve]
• Weiss, R. et al. (2004) Obesity and the metabolic syndrome in children and adolescents, N Engl J Med 350: 2362—2374.[Abstract/Free Full Text]
• Yamamoto, M. et al. (2004) Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese, Biochem Biophys Res Commun 316: 744—748.[CrossRef][Medline] [Order article via Infotrieve]
• Yumuk, V.D. (2006) Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome proliferator-activated receptors, Ann NY Acad Sci 1083: 306—318.[CrossRef][Medline] [Order article via Infotrieve]
• Zeggini, E. et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes, Science 316: 1336—1341.[Abstract/Free Full Text]

Therapeutic Advances in Cardiovascular Disease, Vol. 1, No. 1, 37-47 (2007)
DOI: 10.1177/1753944707082702


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sookoian, S. Articles by Pirola, C. J. Search for Related Content PubMed PubMed Citation Articles by Sookoian, S. Articles by Pirola, C. J. Pubmed/NCBI databases Medline Plus Health Information Metabolic Syndrome Social Bookmarking                         What's this?